Univariate analysis | ||||
---|---|---|---|---|
 | Category | HR1 | 95% CI2 | P |
Clinical and pathological factors | ||||
Age (yrs) | ≥ 72 vs. < 72 | 1.183 | 0.790 - 1.772 | 0.415 |
Gleason score | ≥ 9 vs. < 9 | 1.759 | 1.151 – 2.687 | 0.009 |
PSA (ng/mL) | ≥ 260 vs. < 260 | 1.510 | 0.992 – 2.299 | 0.054 |
HGB (g/dL) | < 11.5 vs. ≥ 11.5 | 2.251 | 1.261 – 4.019 | 0.006 |
ALP (IU/L) | ≥ 350 vs. < 350 | 2.836 | 1.756 – 4.578 | 0.00002 |
LDH (IU/L) | ≥ 500 vs. < 500 | 2.638 | 1.442 – 4.829 | 0.002 |
Genetic factors | Â | Â | Â | Â |
LD block 1 (CA repeat) | 19 rpts (+) vs. (-) | 1.671 | 1.109 – 2.518 | 0.014 |
LD block 2 (rs12423791) | GC + CC vs. GG | 1.658 | 1.102 – 2.495 | 0.015 |
LD block 3 (haplotype) | C-T (+) vs. C-T (-) | 2.054 | 1.373 – 3.075 | 0.0005 |
Number of risk factors | 0 vs. 1–2 vs. 3 | 1.578 | 1.208 – 2.060 | 0.0008 |
0–2 vs. 3 | 2.202 | 1.414 – 3.430 | 0.0005 | |
Multivariate analysis | Â | Â | Â | Â |
Full model | Â | Â | Â | Â |
Age (yrs) | ≥ 72 vs. < 72 | 0.919 | 0.554 – 1.526 | 0.745 |
Gleason score | ≥ 9 vs. < 9 | 1.766 | 1.052 – 2.966 | 0.031 |
PSA (ng/mL) | ≥ 265 vs. < 265 | 0.932 | 0.496 – 1.749 | 0.826 |
HGB (g/dL) | < 11.5 vs. ≥ 11.5 | 2.012 | 0.968 – 4.180 | 0.061 |
ALP (IU/L) | ≥ 350 vs. < 350 | 2.598 | 1.483 – 4.551 | 0.0008 |
LDH (IU/L) | ≥ 500 vs. < 500 | 1.836 | 0.977 – 3.448 | 0.059 |
LD Block 3 (haplotype) | C-T (+) vs. C-T (-) | 2.619 | 1.559 – 4.399 | 0.0003 |
Reduced model | Â | Â | Â | Â |
Gleason score | ≥ 9 vs. < 9 | 1.709 | 1.054 – 2.771 | 0.030 |
HGB (g/dL) | < 11.5 vs. ≥ 11.5 | 2.082 | 1.113 – 3.897 | 0.022 |
ALP (IU/L) | ≥ 350 vs. < 350 | 2.819 | 1.695 – 4.689 | 0.00007 |
LD Block 3 (haplotype) | C-T (+) vs. C-T (-) | 2.626 | 1.603 – 4.305 | 0.0001 |